Journal of Cellular & Molecular Anesthesia

Biggs WS, Demuth RH. Premenstrual syndrome and premenstrual dysphoric disorder. Am Fam Physician. 2011;84(8):918-24.

Braverman PK. Premenstrual Syndrome and Premenstrual Dysphoric Disorder. Journal of Pediatric and Adolescent Gynecology. 2007;20(1):3-12.

Wimalawansa SJ. Non-musculoskeletal benefits of vitamin D. The Journal of steroid biochemistry and molecular biology. 2016.

Straube S, Derry S, Moore RA, McQuay HJ. Vitamin D for the treatment of chronic painful conditions in adults. The Cochrane database of systematic reviews. 2010(1):Cd007771.

Straube S, Andrew Moore R, Derry S, McQuay HJ. Vitamin D and chronic pain. Pain. 2009;141(1-2):10-3.

Backstrom T, Bixo M, Stromberg J. GABAA Receptor-Modulating Steroids in Relation to Women's Behavioral Health. Current psychiatry reports. 2015;17(11):92.

Backstrom T, Andreen L, Birzniece V, Bjorn I, Johansson IM, Nordenstam-Haghjo M, et al. The role of hormones and hormonal treatments in premenstrual syndrome. CNS drugs. 2003;17(5):325-42.

Backstrom T, Sanders D, Leask R, Davidson D, Warner P, Bancroft J. Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome. Psychosomatic medicine. 1983;45(6):503-7.

Rapkin AJ, Akopians AL. Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder. Menopause international. 2012;18(2):52-9.

Lovick TA, Guapo VG, Anselmo-Franci JA, Loureiro CM, Faleiros MC, Del Ben CM, et al. A specific profile of luteal phase progesterone is associated with the development of premenstrual symptoms. Psychoneuroendocrinology. 2016;75:83-90.

Andreen L, Sundstrom-Poromaa I, Bixo M, Nyberg S, Backstrom T. Allopregnanolone concentration and mood--a bimodal association in postmenopausal women treated with oral progesterone. Psychopharmacology. 2006;187(2):209-21.

Paul SM, Purdy RH. Neuroactive steroids. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 1992;6(6):2311-22.

Rupprecht R. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology. 2003;28(2):139-68.

Vanover KE, Suruki M, Robledo S, Huber M, Wieland S, Lan NC, et al. Positive allosteric modulators of the GABA(A) receptor: differential interaction of benzodiazepines and neuroactive steroids with ethanol. Psychopharmacology. 1999;141(1):77-82.

Kuffler SW, Edwards C. Mechanism of gamma aminobutyric acid (GABA) action and its relation to synaptic inhibition. Journal of neurophysiology. 1958;21(6):589-610.

Bäckström T, Bixo M, Johansson M, Nyberg S, Ossewaarde L, Ragagnin G, et al. Allopregnanolone and mood disorders. Progress in Neurobiology. 2014;113:88-94.

Fillingim RB, Ness TJ. Sex-related hormonal influences on pain and analgesic responses. Neuroscience & Biobehavioral Reviews. 2000;24(4):485-501.

Halbreich U, Endicott J. Possible involvement of endorphin withdrawal or imbalance in specific premenstrual syndromes and postpartum depression. Medical Hypotheses. 1981;7(8):1045-58.

Cubeddu A, Bucci F, Giannini A, Russo M, Daino D, Russo N, et al. Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome. Psychoneuroendocrinology. 2011;36(4):523-30.

Slater H, Paananen M, Smith AJ, O'Sullivan P, Briggs AM, Hickey M, et al. Heightened cold pain and pressure pain sensitivity in young female adults with moderate-to-severe menstrual pain. Pain. 2015;156(12):2468-78.

Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Human reproduction update. 2015;21(6):762-78.

Ma H, Hong M, Duan J, Liu P, Fan X, Shang E, et al. Altered Cytokine Gene Expression in Peripheral Blood Monocytes across the Menstrual Cycle in Primary Dysmenorrhea: A Case-Control Study. PLoS ONE. 2013;8(2):e55200.

Piccoli A, Modena F, Calo L, Cantaro S, Avogadro A, Nardo G, et al. Reduction in urinary prostaglandin excretion in the premenstrual syndrome. The Journal of reproductive medicine. 1993;38(12):941-4.

Perez-Hernandez N, Aptilon-Duque G, Nostroza-Hernandez MC, Vargas-Alarcon G, Rodriguez-Perez JM, Blachman-Braun R. Vitamin D and its effects on cardiovascular diseases: a comprehensive review. The Korean journal of internal medicine. 2016;31(6):1018-29.

Michos ED, Selvin E, Misialek JR, McEvoy JW, Ndumele CE, Folsom AR, et al. 25-Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study. Journal of the American Heart Association. 2016;5(11).

Bikle DD. Extraskeletal actions of vitamin D. Annals of the New York Academy of Sciences. 2016;1376(1):29-52.

White JH. Vitamin D metabolism and signaling in the immune system. Reviews in endocrine & metabolic disorders. 2012;13(1):21-9.

Franasiak JM. Vitamin D in human reproduction-an evolving landscape. Fertility and sterility. 2016.

Pacis MM, Fortin CN, Zarek SM, Mumford SL, Segars JH. Vitamin D and assisted reproduction: should vitamin D be routinely screened and repleted prior to ART? A systematic review. Journal of assisted reproduction and genetics. 2015;32(3):323-35.

Rajaei S, Mirahmadian M, Jeddi-Tehrani M, Tavakoli M, Zonoobi M, Dabbagh A, et al. Effect of 1,25(OH)2 vitamin D3 on cytokine production by endometrial cells of women with repeated implantation failure. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2012;28(11):906-11.

Tavakoli M, Jeddi-Tehrani M, Salek-Moghaddam A, Rajaei S, Mohammadzadeh A, Sheikhhasani S, et al. Effects of 1,25(OH)2 vitamin D3 on cytokine production by endometrial cells of women with recurrent spontaneous abortion. Fertility and sterility. 2011;96(3):751-7.

von Kanel R, Muller-Hartmannsgruber V, Kokinogenis G, Egloff N. Vitamin D and central hypersensitivity in patients with chronic pain. Pain medicine (Malden, Mass). 2014;15(9):1609-18.

Jesus CA, Feder D, Peres MF. The role of vitamin D in pathophysiology and treatment of fibromyalgia. Current pain and headache reports. 2013;17(8):355.

Huang W, Shah S, Long Q, Crankshaw AK, Tangpricha V. Improvement of pain, sleep, and quality of life in chronic pain patients with vitamin D supplementation. The Clinical journal of pain. 2013;29(4):341-7.

Tartagni M, Cicinelli MV, Tartagni MV, Alrasheed H, Matteo M, Baldini D, et al. Vitamin D Supplementation for Premenstrual Syndrome-Related Mood Disorders in Adolescents with Severe Hypovitaminosis D. J Pediatr Adolesc Gynecol. 2016;29(4):357-61.

Shehata NA. Calcium versus oral contraceptive pills containing drospirenone for the treatment of mild to moderate premenstrual syndrome: a double blind randomized placebo controlled trial. European journal of obstetrics, gynecology, and reproductive biology. 2016;198:100-4.

Dadkhah H, Ebrahimi E, Fathizadeh N. Evaluating the effects of vitamin D and vitamin E supplement on premenstrual syndrome: A randomized, double-blind, controlled trial. Iranian journal of nursing and midwifery research. 2016;21(2):159-64.

Khajehei M, Abdali K, Parsanezhad ME, Tabatabaee HR. Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome. Int J Gynaecol Obstet. 2009;105(2):158-61.

Thys-Jacobs S, Alvir MJ. Calcium-regulating hormones across the menstrual cycle: evidence of a secondary hyperparathyroidism in women with PMS. J Clin Endocrinol Metab. 1995;80(7):2227-32.

Thys-Jacobs S. Vitamin D and calcium in menstrual migraine. Headache. 1994;34(9):544-6.

Rajaei S, Akbari Sene A, Norouzi S, Berangi Y, Arabian S, Lak P, et al. The relationship between serum vitamin D level and premenstrual syndrome in Iranian women. Int J Reprod Biomed. 2016;14(10):665-8.

Saeedian Kia A, Amani R, Cheraghian B. The Association between the Risk of Premenstrual Syndrome and Vitamin D, Calcium, and Magnesium Status among University Students: A Case Control Study. Health Promot Perspect. 2015;5(3):225-30.

Bertone-Johnson ER, Hankinson SE, Forger NG, Powers SI, Willett WC, Johnson SR, et al. Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study. BMC Womens Health. 2014;14:56.

Obeidat BA, Alchalabi HA, Abdul-Razzak KK, Al-Farras MI. Premenstrual symptoms in dysmenorrheic college students: prevalence and relation to vitamin D and parathyroid hormone levels. Int J Environ Res Public Health. 2012;9(11):4210-22.

Bertone-Johnson ER, Chocano-Bedoya PO, Zagarins SE, Micka AE, Ronnenberg AG. Dietary vitamin D intake, 25-hydroxyvitamin D3 levels and premenstrual syndrome in a college-aged population. The Journal of steroid biochemistry and molecular biology. 2010;121(1-2):434-7.

Thys-Jacobs S, McMahon D, Bilezikian JP. Cyclical changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder. J Clin Endocrinol Metab. 2007;92(8):2952-9.

Bertone-Johnson ER, Hankinson SE, Bendich A, Johnson SR, Willett WC, Manson JE. Calcium and vitamin D intake and risk of incident premenstrual syndrome. Archives of internal medicine. 2005;165(11):1246-52.

Shipton EA, Shipton EE. Vitamin D and Pain: Vitamin D and Its Role in the Aetiology and Maintenance of Chronic Pain States and Associated Comorbidities. Pain Research and Treatment. 2015;2015:904967.

Shipton EE, Shipton EA. Vitamin D Deficiency and Pain: Clinical Evidence of Low Levels of Vitamin D and Supplementation in Chronic Pain States. Pain and therapy. 2015;4(1):67-87.